Patients with biallelic PALB2 variants belong to the FA-N complementation group and have a predisposition to embryonal tumors of childhood such as medulloblastoma, neuroblastoma, and Wilms tumor, similar to FA-D1 patients (9, 10). Here, PALB2 is linked to medulloblastoma.